MedPath
NMPA Approval

Compound Aminophenazone and Barbital Injection

国药准字H13024488

February 3, 2021

国药准字H13024488

Drug Information

复方氨林巴比妥注射液

注射剂(注射液)

2ml:氨基比林0.1g,安替比林40mg,巴比妥18mg

化学药品

February 3, 2021

Company Information

Applicant Company

邛崃市五板桥路18号

Manufacturing Company

邛崃市五板桥路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨林巴比妥注射液 - NMPA 批准文号 | MedPath